The Tissue Engineering and Regenerative Medicine Biomaterials Laboratory The Healtech CDMO plantfrom undertakes the special project of "National 13th Five Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", realizing the transformation of scientific and technological achievements in "Engineering preparation technology and product development of low immunogenicity collagen and silk fibroin protein", and further reserving various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.

At present, we have reserved more than 30 technical projects, applied for eight national nvention patents, obtained five national invention patent certificates, and three medical device registration certificates, three China's first scientific research achievements, completed one medical device raw material master file registration, and provided technical upgrading and new project reserve services for production-type and sales-type enterprises.